Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Iomai Corp.

Division of Valneva SE
www.iomai.com

Latest From Iomai Corp.

Transdermal Drug Delivery: More Than Skin Deep

Start-ups continue to seize opportunities for delivering new and existing drugs transdermally. They are also poised to capitalize on next-generation technologies for delivering macromolecules through the skin. In this issue, we profile AllTranz, Ocelus, Quinnova Pharmaceuticals and Syntropharma.
BioPharmaceutical

Marooned! VCs Stuck in the Public Markets

One group badly hurt by the miserable public market: VCs who remain stuck in companies they took public too early. We review the most threatened companies among those companies that went public since 2003, showing why financing risk is now as important to VCs as regulatory and clinical risk. Meanwhile, current investors are recalibrating, way down, the price at which they can raise new money.
BioPharmaceutical Business Strategies

No Shortage of Disease Markets for Vaccines

Given the recent news about the shortage in supplies of flu vaccine, the potential recurrence of SARS, and increased government funding for vaccines to guard against bioterrorism, the vaccine field is ripe for new company formation and venture capital investment.
BioPharmaceutical Regulation

Iomai Corp.

Start-up company Iomai is developing a transcutaneous immunization technology that allows vaccination through the skin.
BioPharmaceutical
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
    • Drug Delivery
      • Macromolecule
      • Transdermal
    • Vaccines
  • Therapeutic Areas
  • Gastrointestinal
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Valneva SE
  • Senior Management
  • Stanley C Erck, Pres. & CEO
    Kai Chen, PhD, VP, Bus. Dev.
    Larry Ellingsworth, PhD, VP, Research
  • Contact Info
  • Iomai Corp.
    Phone: (301) 556-4500
    20 Firstfield Rd.
    Gaithersburg, MD 20878
    USA
UsernamePublicRestriction

Register